Alexander Cumbo - 16 Jul 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role
Director
Signature
/s/ Sandesh Mahatme, Attorney-in-Fact
Issuer symbol
VOR
Transactions as of
16 Jul 2025
Transactions value $
$0
Form type
4
Filing time
18 Jul 2025, 17:14:07 UTC
Previous filing
06 Jun 2025
Next filing
28 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cumbo Alexander Director C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE /s/ Sandesh Mahatme, Attorney-in-Fact 18 Jul 2025 0001685994

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VOR Stock Option (right to buy) Award $0 +60K $0.00 60K 16 Jul 2025 Common Stock 60K $2.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth of the shares subject to the option shall vest and become exercisable on August 16, 2025 and each month thereafter, subject to the Reporting Person's continued service through each such vesting date.